Joel T. Haas

6.9k total citations · 2 hit papers
48 papers, 4.8k citations indexed

About

Joel T. Haas is a scholar working on Epidemiology, Molecular Biology and Surgery. According to data from OpenAlex, Joel T. Haas has authored 48 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Epidemiology, 16 papers in Molecular Biology and 13 papers in Surgery. Recurrent topics in Joel T. Haas's work include Liver Disease Diagnosis and Treatment (17 papers), Lipid metabolism and biosynthesis (10 papers) and Peroxisome Proliferator-Activated Receptors (7 papers). Joel T. Haas is often cited by papers focused on Liver Disease Diagnosis and Treatment (17 papers), Lipid metabolism and biosynthesis (10 papers) and Peroxisome Proliferator-Activated Receptors (7 papers). Joel T. Haas collaborates with scholars based in United States, France and Belgium. Joel T. Haas's co-authors include Bart Staels, Robert V. Farese, Tobias C. Walther, Sven Francque, Audrey Deprince, Florian Wilfling, Sudha B. Biddinger, C. Ronald Kahn, Martin C. Carey and Rudolf Zechner and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Joel T. Haas

46 papers receiving 4.7k citations

Hit Papers

2 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Triacylglycerol Synthesis Enzymes Mediate Lipid Droplet Growth by Relocalizing from the ER to Lipid Droplets

2013 618 citations Florian Wilfling, Huajin Wang et al. Developmental Cell profile →
Dysregulated lipid metabolism links NAFLD to cardiovascular disease

2020 350 citations Joel T. Haas, Bart Staels et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joel T. Haas United States	30	2.0k	1.7k	1.6k	1.1k	1.0k	48	4.8k
Sylvaine Cases United States	17	2.6k 1.3×	2.8k 1.7×	830 0.5×	1.3k 1.2×	1.3k 1.3×	21	5.3k
Pradip Saha United States	36	2.1k 1.1×	631 0.4×	1.7k 1.1×	1.8k 1.6×	785 0.8×	76	5.5k
Jinny S. Wong United States	27	2.0k 1.0×	1.3k 0.8×	676 0.4×	671 0.6×	1.2k 1.1×	31	4.1k
Paloma Martı́n-Sanz Spain	37	2.1k 1.0×	620 0.4×	1.3k 0.8×	606 0.5×	526 0.5×	119	5.0k
Anil K. Agarwal United States	43	4.1k 2.1×	1.3k 0.8×	589 0.4×	1.3k 1.2×	822 0.8×	127	7.0k
Thomas O. Eichmann Austria	33	2.0k 1.0×	1.6k 1.0×	738 0.5×	1.5k 1.4×	677 0.7×	84	4.6k
Guosheng Liang United States	35	3.8k 1.9×	1.3k 0.8×	1.7k 1.1×	1.7k 1.5×	3.6k 3.5×	60	8.4k
Juliane Gertrude Bogner‐Strauß Austria	29	1.9k 0.9×	2.2k 1.3×	853 0.5×	2.2k 2.0×	788 0.8×	48	4.6k
Isabelle Dugail France	39	2.5k 1.2×	841 0.5×	1.2k 0.8×	1.7k 1.5×	974 1.0×	94	4.7k
Youqing Xiang United States	8	1.5k 0.7×	973 0.6×	2.9k 1.8×	824 0.7×	434 0.4×	9	4.2k

Countries citing papers authored by Joel T. Haas

Since Specialization

Citations

This map shows the geographic impact of Joel T. Haas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel T. Haas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel T. Haas more than expected).

Fields of papers citing papers by Joel T. Haas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joel T. Haas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel T. Haas. The network helps show where Joel T. Haas may publish in the future.

Co-authorship network of co-authors of Joel T. Haas

This figure shows the co-authorship network connecting the top 25 collaborators of Joel T. Haas. A scholar is included among the top collaborators of Joel T. Haas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joel T. Haas. Joel T. Haas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Hua, Marie Lhomme, Sophie Galier, et al.. (2025). MAIT Cells Promote Cholesterol Excretion Pathways Mitigating Atherosclerosis. Circulation Research. 136(9). 968–981.

Berthier, Alexandre, Céline Gheeraert, Manjula Vinod, et al.. (2025). Unveiling the molecular legacy of transient insulin resistance: Implications for hepatic metabolic adaptability. Journal of Hepatology. 83(2). 315–328. 1 indexed citations

Kong, Wan Ting, et al.. (2024). The immunological interface: dendritic cells as key regulators in metabolic dysfunction‐associated steatotic liver disease. FEBS Letters. 599(14). 1971–1981. 1 indexed citations

L’homme, Laurent, Joel T. Haas, Sébastien Fleury, et al.. (2024). Adipose tissue macrophage infiltration and hepatocyte stress increase GDF-15 throughout development of obesity to MASH. Nature Communications. 15(1). 7173–7173. 12 indexed citations

Grzych, Guillaume, Oscar Chávez‐Talavera, Amandine Descat, et al.. (2020). NASH-related increases in plasma bile acid levels depend on insulin resistance. JHEP Reports. 3(2). 100222–100222. 48 indexed citations

Pourcet, Benoît, Lise Ferri, Cyrielle Billon, et al.. (2017). Nuclear Receptor Subfamily 1 Group D Member 1 Regulates Circadian Activity of NLRP3 Inflammasome to Reduce the Severity of Fulminant Hepatitis in Mice. Gastroenterology. 154(5). 1449–1464.e20. 170 indexed citations

Chitraju, Chandramohan, Niklas Mejhert, Joel T. Haas, et al.. (2017). Triglyceride Synthesis by DGAT1 Protects Adipocytes from Lipid-Induced ER Stress during Lipolysis. Cell Metabolism. 26(2). 407–418.e3. 259 indexed citations

Haas, Joel T. & Bart Staels. (2017). Fasting the Microbiota to Improve Metabolism?. Cell Metabolism. 26(4). 584–585. 8 indexed citations

Legry, Vanessa, Sven Francque, Joel T. Haas, et al.. (2017). Bile Acid Alterations Are Associated With Insulin Resistance, but Not With NASH, in Obese Subjects. The Journal of Clinical Endocrinology & Metabolism. 102(10). 3783–3794. 79 indexed citations

10.

Wilfling, Florian, Huajin Wang, Joel T. Haas, et al.. (2013). Triacylglycerol Synthesis Enzymes Mediate Lipid Droplet Growth by Relocalizing from the ER to Lipid Droplets. Developmental Cell. 24(4). 384–399. 618 indexed citations breakdown →

11.

Xu, Ningyi, Sean McKinney, Fengli Guo, et al.. (2012). The FATP1–DGAT2 complex facilitates lipid droplet expansion at the ER–lipid droplet interface. The Journal of Cell Biology. 198(5). 895–911. 227 indexed citations

12.

Haas, Joel T., Harland S. Winter, Elaine T. Lim, et al.. (2012). DGAT1 mutation is linked to a congenital diarrheal disorder. Journal of Clinical Investigation. 122(12). 4680–4684. 115 indexed citations

13.

Haas, Joel T., Ji Miao, Dipanjan Chanda, et al.. (2012). Hepatic Insulin Signaling Is Required for Obesity-Dependent Expression of SREBP-1c mRNA but Not for Feeding-Dependent Expression. Cell Metabolism. 15(6). 873–884. 155 indexed citations

14.

Bézy, Olivier, Thien T. Tran, Jussi Pihlajamäki, et al.. (2011). PKCδ regulates hepatic insulin sensitivity and hepatosteatosis in mice and humans. Journal of Clinical Investigation. 121(6). 2504–2517. 115 indexed citations

15.

Haas, Joel T., Arno Beer, Karin Salzmann, et al.. (2011). LRP1b shows restricted expression in human tissues and binds to several extracellular ligands, including fibrinogen and apoE – carrying lipoproteins. Atherosclerosis. 216(2). 342–347. 35 indexed citations

16.

Caron, Sandrine, An Verrijken, Ilse Mertens, et al.. (2010). Transcriptional Activation of Apolipoprotein CIII Expression by Glucose May Contribute to Diabetic Dyslipidemia. Arteriosclerosis Thrombosis and Vascular Biology. 31(3). 513–519. 122 indexed citations

17.

Haas, Joel T. & Sudha B. Biddinger. (2009). Dissecting the role of insulin resistance in the metabolic syndrome. Current Opinion in Lipidology. 20(3). 206–210. 59 indexed citations

18.

Biddinger, Sudha B., Joel T. Haas, Olivier Bézy, et al.. (2008). Hepatic insulin resistance directly promotes formation of cholesterol gallstones. Nature Medicine. 14(7). 778–782. 254 indexed citations

19.

Zaheer, Asgar, Asgar Zaheer, Shailendra K. Sahu, et al.. (2007). Diminished cytokine and chemokine expression in the central nervous system of GMF-deficient mice with experimental autoimmune encephalomyelitis. Brain Research. 1144. 239–247. 36 indexed citations

20.

Menon, Krishnakumar N., Yanghong Wu, Joel T. Haas, et al.. (2007). Diminished degradation of myelin basic protein by anti-sulfatide antibody and interferon-γ in myelin from glia maturation factor-deficient mice. Neuroscience Research. 58(2). 156–163. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact